News Focus
News Focus
icon url

lineItemVeto

09/28/18 4:56 PM

#44958 RE: Inertech #44955

Wonder if anybody asked PWC, or Vasolis, or LCY these questions? They might have answers
icon url

TenKay

09/28/18 5:07 PM

#44960 RE: Inertech #44955

What makes you think there is a “share transfer” to the new company?

There is not a single document disclosed that supports that notion.

LCY Chemical is a publicly traded company, if someone wants to buy their shares they can on the Taiwan stock exchange..

LCY Biotechnology is a private JV company owned by LCY Chemical and Visolis. Those shares cannot be bought publicly.
icon url

kevroc

09/28/18 6:20 PM

#44976 RE: Inertech #44955

That will not happen here.
The buyers have formed a private company and would need to do an IPO of their own shares before they could swap with BIOA.

LCY parent trades on Taiwan market.

IMO, they might possibly reverse merge into the BIOA shell in order to get shares trading on TSX and NYSE in a very short period of time. That means they MUST get the share price back over $2 minimum, maybe $3.

Once they have full control, they can authorize more shares, share classes, change the O/S... and basically do whatever they want.

Fun, huh? :-)